SCHEMBL9508917

SCHEMBL9508917

Cc1ccccc1Nc1nc(Nc2ccccc2C)c2cccc(OC(C)O)c2n1

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9510898 0.93
SCHEMBL9508885 0.84 SLC2A1 (0.57) SLC2A1
Hydrochloric Acid SCHEMBL9776703 0.83 SLC2A1 (0.56) SLC2A1
SCHEMBL9508260 0.79 SLC2A1 (0.54) SLC2A1
SCHEMBL9510869 0.77
SCHEMBL9776719 0.77
Hydrochloric Acid SCHEMBL9776804 0.76
SCHEMBL9508862 0.76 MEN1 (0.56)
SCHEMBL9508913 0.76 HTR1B (0.49)
Hydrochloric Acid SCHEMBL9776658 0.75 SLC2A1 (0.56) SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0404322-B1 QUINAZOLINE DERIVATIVES SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1993-09-22 EP claimed
EP-0404322-B1 QUINAZOLINE DERIVATIVES SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1993-09-22 EP disclosed
US-5064833-A Substituted quinazoline derivatives for use in gastrointestinal diseases SMITHKLINE BEECHAM INTERCREDIT B.V. (GB) 1991-11-12 US disclosed
EP-0404322-A1 Quinazoline derivatives SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1990-12-27 EP disclosed